ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-34J18257
Home | Market Reports | Health| Pharmacy
Global Human Granulocyte Macrophage Colony stimulating Factor for Injection Market Research Report 2024
BUY CHAPTERS

Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Research Report 2024

Code: QYRE-Auto-34J18257
Report
November 2024
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Partner Therapeutics
Changchun GeneScience Pharmaceutical
North China Pharmaceutical
Amoytop Biotech
Hainan Unipul Pharmaceutical
Harbin Pharmaceutical Group
Guangzhou Baiyunshan Pharmaceutical

Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market

The global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Human Granulocyte/Macrophage Colony-Stimulating Factor for Injection (GM-CSF) is a recombinant protein that stimulates the production, differentiation, and activation of both granulocytes (such as neutrophils) and macrophages, which are crucial components of the immune system. Clinically, GM-CSF is used to accelerate white blood cell recovery in patients undergoing chemotherapy, bone marrow transplantation, or other treatments that suppress immune function. Additionally, GM-CSF is sometimes applied in immunotherapy protocols to boost immune activity against infections or certain cancers.
North American market for Human Granulocyte/Macrophage Colony-stimulating Factor for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Granulocyte/Macrophage Colony-stimulating Factor for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection include Partner Therapeutics, Changchun GeneScience Pharmaceutical, North China Pharmaceutical, Amoytop Biotech, Hainan Unipul Pharmaceutical, Harbin Pharmaceutical Group, Guangzhou Baiyunshan Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Granulocyte/Macrophage Colony-stimulating Factor for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Granulocyte/Macrophage Colony-stimulating Factor for Injection.
The Human Granulocyte/Macrophage Colony-stimulating Factor for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Granulocyte/Macrophage Colony-stimulating Factor for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Report

Report Metric Details
Report Name Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Partner Therapeutics, Changchun GeneScience Pharmaceutical, North China Pharmaceutical, Amoytop Biotech, Hainan Unipul Pharmaceutical, Harbin Pharmaceutical Group, Guangzhou Baiyunshan Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market report?

Ans: The main players in the Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market are Partner Therapeutics, Changchun GeneScience Pharmaceutical, North China Pharmaceutical, Amoytop Biotech, Hainan Unipul Pharmaceutical, Harbin Pharmaceutical Group, Guangzhou Baiyunshan Pharmaceutical

What are the Application segmentation covered in the Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market report?

Ans: The Applications covered in the Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market report?

Ans: The Types covered in the Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market report are Subcutaneous Injection, Intravenous Injection

Recommended Reports

Cell & Gene Therapy

Stem Cell Markets

Hematology & Growth Factors

1 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Overview
1.1 Product Definition
1.2 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection by Type
1.2.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Value Comparison by Type (2024-2030)
1.2.2 Subcutaneous Injection
1.2.3 Intravenous Injection
1.3 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection by Application
1.3.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Size Estimates and Forecasts
1.4.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue 2019-2030
1.4.2 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales 2019-2030
1.4.3 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Competition by Manufacturers
2.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection, Product Type & Application
2.7 Global Key Manufacturers of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection, Date of Enter into This Industry
2.8 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Competitive Situation and Trends
2.8.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Players Market Share by Revenue
2.8.3 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Scenario by Region
3.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Region: 2019-2030
3.2.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Region: 2019-2024
3.2.2 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Region: 2025-2030
3.3 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Region: 2019-2030
3.3.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Region: 2019-2024
3.3.2 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Region: 2025-2030
3.4 North America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Facts & Figures by Country
3.4.1 North America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2019-2030)
3.4.3 North America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Facts & Figures by Country
3.5.1 Europe Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2019-2030)
3.5.3 Europe Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Facts & Figures by Country
3.7.1 Latin America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2019-2030)
3.7.3 Latin America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Type (2019-2030)
4.1.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Type (2019-2024)
4.1.2 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Type (2025-2030)
4.1.3 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Type (2019-2030)
4.2 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Type (2019-2030)
4.2.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Type (2019-2024)
4.2.2 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Type (2025-2030)
4.2.3 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Application (2019-2030)
5.1.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Application (2019-2024)
5.1.2 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Application (2025-2030)
5.1.3 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Application (2019-2030)
5.2 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Application (2019-2030)
5.2.1 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Application (2019-2024)
5.2.2 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Application (2025-2030)
5.2.3 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Partner Therapeutics
6.1.1 Partner Therapeutics Company Information
6.1.2 Partner Therapeutics Description and Business Overview
6.1.3 Partner Therapeutics Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Partner Therapeutics Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product Portfolio
6.1.5 Partner Therapeutics Recent Developments/Updates
6.2 Changchun GeneScience Pharmaceutical
6.2.1 Changchun GeneScience Pharmaceutical Company Information
6.2.2 Changchun GeneScience Pharmaceutical Description and Business Overview
6.2.3 Changchun GeneScience Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Changchun GeneScience Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product Portfolio
6.2.5 Changchun GeneScience Pharmaceutical Recent Developments/Updates
6.3 North China Pharmaceutical
6.3.1 North China Pharmaceutical Company Information
6.3.2 North China Pharmaceutical Description and Business Overview
6.3.3 North China Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 North China Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product Portfolio
6.3.5 North China Pharmaceutical Recent Developments/Updates
6.4 Amoytop Biotech
6.4.1 Amoytop Biotech Company Information
6.4.2 Amoytop Biotech Description and Business Overview
6.4.3 Amoytop Biotech Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amoytop Biotech Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product Portfolio
6.4.5 Amoytop Biotech Recent Developments/Updates
6.5 Hainan Unipul Pharmaceutical
6.5.1 Hainan Unipul Pharmaceutical Company Information
6.5.2 Hainan Unipul Pharmaceutical Description and Business Overview
6.5.3 Hainan Unipul Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hainan Unipul Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product Portfolio
6.5.5 Hainan Unipul Pharmaceutical Recent Developments/Updates
6.6 Harbin Pharmaceutical Group
6.6.1 Harbin Pharmaceutical Group Company Information
6.6.2 Harbin Pharmaceutical Group Description and Business Overview
6.6.3 Harbin Pharmaceutical Group Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Harbin Pharmaceutical Group Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product Portfolio
6.6.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.7 Guangzhou Baiyunshan Pharmaceutical
6.7.1 Guangzhou Baiyunshan Pharmaceutical Company Information
6.7.2 Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
6.7.3 Guangzhou Baiyunshan Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Guangzhou Baiyunshan Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product Portfolio
6.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Industry Chain Analysis
7.2 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Production Mode & Process
7.4 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales and Marketing
7.4.1 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Channels
7.4.2 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Distributors
7.5 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Customers
8 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Dynamics
8.1 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Industry Trends
8.2 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Drivers
8.3 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Challenges
8.4 Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Partner Therapeutics
Changchun GeneScience Pharmaceutical
North China Pharmaceutical
Amoytop Biotech
Hainan Unipul Pharmaceutical
Harbin Pharmaceutical Group
Guangzhou Baiyunshan Pharmaceutical
List of Tables
 Table 1. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Granulocyte/Macrophage Colony-stimulating Factor for Injection as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Region (2019-2024) & (K Units)
 Table 18. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Region (2019-2024)
 Table 19. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Region (2025-2030) & (K Units)
 Table 20. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Region (2025-2030)
 Table 21. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Region (2019-2024)
 Table 23. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Region (2025-2030)
 Table 25. North America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2019-2024) & (K Units)
 Table 27. North America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2025-2030) & (K Units)
 Table 28. North America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units) by Type (2019-2024)
 Table 51. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units) by Type (2025-2030)
 Table 52. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Type (2019-2024)
 Table 53. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Type (2025-2030)
 Table 54. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Type (2019-2024)
 Table 57. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Type (2025-2030)
 Table 58. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units) by Application (2019-2024)
 Table 61. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units) by Application (2025-2030)
 Table 62. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Application (2019-2024)
 Table 63. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Application (2025-2030)
 Table 64. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Application (2019-2024)
 Table 67. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Application (2025-2030)
 Table 68. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Price (US$/Unit) by Application (2025-2030)
 Table 70. Partner Therapeutics Company Information
 Table 71. Partner Therapeutics Description and Business Overview
 Table 72. Partner Therapeutics Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Partner Therapeutics Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product
 Table 74. Partner Therapeutics Recent Developments/Updates
 Table 75. Changchun GeneScience Pharmaceutical Company Information
 Table 76. Changchun GeneScience Pharmaceutical Description and Business Overview
 Table 77. Changchun GeneScience Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Changchun GeneScience Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product
 Table 79. Changchun GeneScience Pharmaceutical Recent Developments/Updates
 Table 80. North China Pharmaceutical Company Information
 Table 81. North China Pharmaceutical Description and Business Overview
 Table 82. North China Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. North China Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product
 Table 84. North China Pharmaceutical Recent Developments/Updates
 Table 85. Amoytop Biotech Company Information
 Table 86. Amoytop Biotech Description and Business Overview
 Table 87. Amoytop Biotech Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Amoytop Biotech Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product
 Table 89. Amoytop Biotech Recent Developments/Updates
 Table 90. Hainan Unipul Pharmaceutical Company Information
 Table 91. Hainan Unipul Pharmaceutical Description and Business Overview
 Table 92. Hainan Unipul Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Hainan Unipul Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product
 Table 94. Hainan Unipul Pharmaceutical Recent Developments/Updates
 Table 95. Harbin Pharmaceutical Group Company Information
 Table 96. Harbin Pharmaceutical Group Description and Business Overview
 Table 97. Harbin Pharmaceutical Group Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Harbin Pharmaceutical Group Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product
 Table 99. Harbin Pharmaceutical Group Recent Developments/Updates
 Table 100. Guangzhou Baiyunshan Pharmaceutical Company Information
 Table 101. Guangzhou Baiyunshan Pharmaceutical Description and Business Overview
 Table 102. Guangzhou Baiyunshan Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Guangzhou Baiyunshan Pharmaceutical Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Product
 Table 104. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Distributors List
 Table 108. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Customers List
 Table 109. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Trends
 Table 110. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Drivers
 Table 111. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Challenges
 Table 112. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection
 Figure 2. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Share by Type: 2023 & 2030
 Figure 4. Subcutaneous Injection Product Picture
 Figure 5. Intravenous Injection Product Picture
 Figure 6. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales (2019-2030) & (K Units)
 Figure 14. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Average Price (US$/Unit) & (2019-2030)
 Figure 15. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Report Years Considered
 Figure 16. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Share by Manufacturers in 2023
 Figure 17. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Players: Market Share by Revenue in Human Granulocyte/Macrophage Colony-stimulating Factor for Injection in 2023
 Figure 19. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Country (2019-2030)
 Figure 22. North America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Country (2019-2030)
 Figure 23. United States Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Country (2019-2030)
 Figure 26. Europe Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Region (2019-2030)
 Figure 34. China Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection by Type (2019-2030)
 Figure 53. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Human Granulocyte/Macrophage Colony-stimulating Factor for Injection by Application (2019-2030)
 Figure 56. Global Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Price (US$/Unit) by Application (2019-2030)
 Figure 57. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Value Chain
 Figure 58. Human Granulocyte/Macrophage Colony-stimulating Factor for Injection Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Granulocyte Macrophage Colony Stimulating Factor GM CSF Market Research Report 2024
Global Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Global PEGylated Granulocyte Colony Stimulating Factor Market Research Report 2024
Global Recombinant Human Granulocyte Colony Stimulating Factor Injection rhG CSF Market Research Report 2025
Global Human Granulocyte Colony Stimulating Factor for Injection Market Research Report 2024
Global Long acting Granulocyte Colony Stimulating Factor G CSF Market Research Report 2024
Granulocyte Colony Stimulating Factor G CSF Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human GM CSF for Injection Market Research Report 2024
Global Macrophage Stimulating Protein Receptor Market Research Report 2025
Human Growth Hormone for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Stem Cell Growth Factors Market Research Report 2025
Global Granulocyte Macrophage Colony Stimulating Factor GM CSF ELISA Kit Market Research Report 2024
Global Macrophage Colony Stimulating Factor Reagent Market Research Report 2025
Global Human Bone Marrow Product Market Research Report 2024
Global Injection Human Interleukin 2 Market Research Report 2025
Global Hepatocyte Growth promoting Hormone for Injection Market Research Report 2024
Global Stem Cell Cytokines Market Research Report 2024
Global Human Recombinant Growth Factors Market Research Report 2025
Global Recombinant Human Granulocyte Colony Stimulating Market Insights Forecast to 2030
Global Recombinant Human M CSF Protein Market Research Report 2025

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions